Claris Lifesciences has extended Thursday's gain on Friday. The company has received MHRA approval for its newly commissioned plant.

"This will help in enhancing capacities to grow in the regulated markets, especially the European Union. The company's specialty injectables business saw a growth of 30% in the last quarter," the company said.

Shares of the company are trading at Rs 183.60, up Rs 2, or 1.10% at the Bombay Stock Exchange (BSE) on Friday at 10:33 a.m.

The scrip has touched an intra-day high of Rs 187 and low of Rs 183. The total volume of shares traded at the BSE is 23,348.

In the earlier session, the shares climbed 3.56%, or Rs 6.25, at Rs 181.60.